Recent developments highlight Healthy Extracts' record revenue growth, strategic partnerships, product launches, and financial activities including financing arrangements.

• Healthy Extracts reported 2025 net revenue up 45% to a record $4.5 million, reflecting strong growth in its nutraceutical product sales [N6][S1].
• The company announced a strategic manufacturing and commercial partnership with Gelteq to expand gel-based nutrition technologies [N8][S1].
• Healthy Extracts completed a transformative merger with Gummy USA, enhancing its gummy nutraceutical product offerings and securing a 6 million gummy follow-on order from a women's health nutraceutical leader [N6][S1].
• The company launched new products including STAT10, a CoQ10 and nutrient support formulation for statin users, and an anti-aging formulation called LONGEVITY [N6][S1].
• Financial data as of Q2 2026 shows revenue of approximately $2.07 million but a net loss of $129,389 and liquidity ratios indicating financial stress, with current liabilities significantly exceeding current assets [S2].
• Healthy Extracts issued promissory notes in 2026 as part of financing activities to support operations, including a $258,750 note with a 10% interest rate and conversion features [S2].

Healthy Extracts has demonstrated strong revenue growth and product innovation, supported by strategic partnerships and acquisitions that enhance its manufacturing and commercial capabilities. Its focus on high-growth nutraceutical categories and ability to secure significant orders from industry leaders indicate active market traction. The company's expanding product portfolio and presence on major retail channels provide avenues for continued commercial execution and brand development.

Despite revenue growth, Healthy Extracts faces liquidity challenges as indicated by a low current ratio and net losses in recent quarters. The company's financial position may constrain its ability to invest in growth initiatives or respond to competitive pressures. The nutraceutical market is competitive and subject to regulatory scrutiny, which could impact product acceptance and sales. Execution risks include integration of acquisitions and maintaining innovation momentum under financial constraints.

Healthy Extracts' moat is based on its proprietary nutraceutical formulations, strategic partnerships for manufacturing and distribution, and its acquisition of specialized gummy technology through Gummy USA. The company's focus on innovative gel-based nutrition products and targeted health formulations provides differentiation in the competitive nutraceutical market. Its ability to secure large orders and presence on major retail platforms like Amazon further supports its market position. However, the moat is subject to risks from liquidity constraints and competitive pressures in the nutraceutical industry.

• Liquidity Risk: The company's current ratio of 0.2 and cash ratio of 0.01 as of June 30, 2026, indicate significant liquidity constraints that may impact operational flexibility.
• Market Competition: The nutraceutical sector is highly competitive with many players offering similar products, which could pressure pricing and market share.
• Execution Risk: Integration of acquisitions such as Gummy USA and successful commercialization of new products are critical to sustaining growth.
• Regulatory Risk: Nutraceutical products are subject to regulatory oversight which could affect product approvals, marketing, and sales.

• Healthy Extracts Inc. operates in the nutraceutical technology sector, focusing on innovative nutritional supplements and gel-based nutrition technologies.
• The company reported record net revenue of $4.5 million for 2025, representing a 45% increase over the prior year, as disclosed in April 2026 press releases and SEC filings [N6][N7][S1].
• Healthy Extracts has formed a strategic manufacturing and commercial partnership with Gelteq to expand gel-based nutrition technologies [N8].
• The company reported record quarterly revenues in Q3 2025 with a 23% increase, and similarly strong quarterly results in 2024, including a 54% revenue increase in Q2 2024 [N6][N7][S1].
• Healthy Extracts completed a transformative merger with Gummy USA, a precision-dosed nutraceutical gummy technology innovator and manufacturer, enhancing its product offerings and market reach [N6][S1].
• The company launched new nutraceutical products including STAT10, a CoQ10 and nutrient support formulation targeting statin users, and an anti-aging formulation called LONGEVITY [N6][S1].
• Healthy Extracts has engaged in multiple growth initiatives including Amazon Prime Day product launches and securing large follow-on orders from nutraceutical leaders [N6][S1].
• Financial snapshot as of June 30, 2026, shows revenue of approximately $2.07 million for Q2 2026, a net loss of $129,389, current assets of $1.68 million, current liabilities of $8.39 million, resulting in a current ratio of 0.2 and a cash ratio of 0.01, indicating liquidity constraints [S2].
• The company issued promissory notes and entered into securities purchase agreements in 2026, indicating financing activities to support operations [S2].